НовостиBenzingaGuggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $150 Guggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $150 Benzinga 2026.10.02 13:05 (GMT+0) Открыть на Benzinga Другие новости